Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ying Ma
Affiliation
National Institutes of Health
ORCID
Career Start Year
1994
Papers
128
H Index
41
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35606352
A genetic engineering strategy for editing near-infrared-II fluorophores.
Nat Commun
2022
34210986
Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.
Nat Commun
2021
32550894
Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery.
Theranostics
2020
31877023
Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
ACS Nano
2020
33310853
Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy.
Sci Adv
2020
33206522
Reactive Oxygen Species Activatable Heterodimeric Prodrug as Tumor-Selective Nanotheranostics.
ACS Nano
2020
32656801
Targeting Neutrophils for Enhanced Cancer Theranostics.
Adv Mater
2020
33009382
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death.
Nat Commun
2020
30300471
Antidiabetic Effect of Abextide, a Long-Acting Exendin-4 Analogue in Cynomolgus Monkeys.
Adv Healthc Mater
2019
31244923
Core-shell metal-organic frameworks with fluorescence switch to trigger an enhanced photodynamic therapy.
Theranostics
2019
31181890
Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
Bioconjug Chem
2019
31317730
Tumor Microenvironment-Activated Ultrasensitive Nanoprobes for Specific Detection of Intratumoral Glutathione by Ratiometric Photoacoustic Imaging.
ACS Appl Mater Interfaces
2019
31374171
Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
ACS Nano
2019
31402203
3-<sup>18</sup>F-fluoropropane-1-thiol and <sup>18</sup>F-PEG<sub>4</sub>-1-thiol: Versatile prosthetic groups for radiolabeling maleimide functionalized peptides.
Bioorg Med Chem
2019
30867836
A Logic-Gated Modular Nanovesicle Enables Programmable Drug Release for On-Demand Chemotherapy.
Theranostics
2019
31117347
An Albumin-Binding T<sub>1</sub>- T<sub>2</sub> Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging.
Bioconjug Chem
2019
30886808
Tumor-Specific Drug Release and Reactive Oxygen Species Generation for Cancer Chemo/Chemodynamic Combination Therapy.
Adv Sci (Weinh)
2019
31082207
An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides.
Bioconjug Chem
2019
30575388
Ratiometric Photoacoustic Nanoprobe for Bioimaging of Cu<sup>2</sup>.
ACS Appl Mater Interfaces
2019
29344302
Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy.
Theranostics
2018
30105912
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors.
Bioconjug Chem
2018
29738963
Purification of R-phycoerythrin from Gracilaria lemaneiformis by centrifugal precipitation chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci
2018
29624828
Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy.
Angew Chem Int Ed Engl
2018
29456156
A multilayer coil in type-I counter-current chromatography.
J Chromatogr A
2018
29556370
A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Theranostics
2018
29254329
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN<sub>7-14</sub> and Antagonist RM26.
Bioconjug Chem
2018
27879373
Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
J Nucl Med
2017
28224711
Ratiometric Photoacoustic Molecular Imaging for Methylmercury Detection in Living Subjects.
Adv Mater
2017
28277675
Correction to "Novel <sup>19</sup>F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS".
Mol Pharm
2017
29203865
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.
Nat Commun
2017
29176623
Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy.
Nat Commun
2017
28858467
Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
ACS Nano
2017
28744320
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.
Theranostics
2017
26818100
Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter.
Nanoscale
2016
26641886
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Bioconjug Chem
2016
27149392
A photothermally responsive nanoprobe for bioimaging based on Edman degradation.
Nanoscale
2016
26877782
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.
Theranostics
2016
25698784
PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer.
J Nucl Med
2015
26568270
A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO.
Nanoscale
2015
26382146
Protein-based photothermal theranostics for imaging-guided cancer therapy.
Nanoscale
2015
26315836
18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
J Nucl Med
2015
26086295
Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene.
Bioconjug Chem
2015
25976126
Fabrication of chiral amino acid ionic liquid modified magnetic multifunctional nanospheres for centrifugal chiral chromatography separation of racemates.
J Chromatogr A
2015
23982795
Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.
Mol Imaging Biol
2014
25476690
Enantioseparation of (DL)-tryptophan by spiral tube assembly counter-current chromatography and evaluation of mass transfer rate for enantiomers.
J Chromatogr A
2014
25285166
Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.
Theranostics
2014
25224367
PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.
Biomaterials
2014
25271556
Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS.
Mol Pharm
2014
24842890
In Vivo Labeling of Serum Albumin for PET.
J Nucl Med
2014
24798315
One-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imaging.
Mol Pharm
2014
1 - 50 of 128
Column Actions
Search
Recommended Authors
Tony L Huynh
University of California san francisco
Career Start Year
2014
Number of shared co-authors
0
Vincenzo Paolillo
UT MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
1
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year
2007
Number of shared co-authors
0
Peter J H Scott
University of Michigan Medical School ann arbor
Career Start Year
2007
Number of shared co-authors
2
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
0
Alfonso Espada
Career Start Year
2003
Number of shared co-authors
0
Bing Bai
Hefei National Laboratory, University of Science and Technology of China
Career Start Year
2002
Number of shared co-authors
3
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Deng Pan
College of Plant Protection, Southwest University
Career Start Year
2001
Number of shared co-authors
0
Eric Gangl
Oncology R&D
Career Start Year
1998
Number of shared co-authors
0
??kos V??gv??ri
Karolinska Institutet
Career Start Year
1998
Number of shared co-authors
0
Niki M Zacharias
MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
1994
Number of shared co-authors
0
Huy Nguyen
The University of Danang-University of Science and Technology
Career Start Year
1993
Number of shared co-authors
0
Mark Namchuk
Blavatnik Institute, Harvard Medical School
Career Start Year
1990
Number of shared co-authors
0
Christopher P Austin
St. George's University Medical School
Career Start Year
1990
Number of shared co-authors
1
Jonathan V Sweedler
University of Illinois at Urbana-Champaign
Career Start Year
1990
Number of shared co-authors
0
Pablo Avil??s
Departamento de Toxicologia y Farmacologia Preclinica
Career Start Year
1989
Number of shared co-authors
0
Oliver Kretz
University Medical Center Hamburg-Eppendorf
Career Start Year
1989
Number of shared co-authors
0
Sally Freeman
Division of Pharmacy and Optometry, University of Manchester
Career Start Year
1988
Number of shared co-authors
0
Stephen Naylor
ReNeuroGen LLC
Career Start Year
1985
Number of shared co-authors
0
Michael J Adam
University of Washington School of Medicine
Career Start Year
1984
Number of shared co-authors
0
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Career Start Year
1973
Number of shared co-authors
0
Alexander D Sherry
University of Texas MD Anderson Cancer Center
Career Start Year
1972
Number of shared co-authors
0
Pradeep K Garg
Wake Forest University School of Medicine
Career Start Year
1972
Number of shared co-authors
1
Edouard C Nice
Monash University
Career Start Year
1971
Number of shared co-authors
0
Wei-Chiang Shen
Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences
Career Start Year
1969
Number of shared co-authors
1
Leslie M Shaw
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1968
Number of shared co-authors
1
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year
1967
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers
80
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers
62
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers
59
Lixin Lang
First Hospital of Shanxi Medical University, Shanxi Medical University
Co-authored papers
42
Lei Zhu
Emory University School of Medicine
Co-authored papers
19
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Co-authored papers
9
Seulki Lee
The Johns Hopkins University School of Medicine
Co-authored papers
6
Richard E Carson
Yale University
Co-authored papers
5
Jinxia Guo
Co-authored papers
5
Fan Zhang
The Second Hospital of Dalian Medical University
Co-authored papers
4
Chenxi Wu
College of Clinical Medicine, Jining Medical University
Co-authored papers
3
Kenneth A Jacobson
National Institutes of Health
Co-authored papers
2
Abesh Kumar Bhattacharjee
University of California San Diego.
Co-authored papers
2
Henry S Eden
Co-authored papers
2
Hak Soo Choi
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
1
Qingguo Xie
College of Life Science and Technology, Huazhong University of Science and Technology
Co-authored papers
1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers
1
Zhan-Guo Gao
National Institutes of Health
Co-authored papers
1
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
1
Mei He
Sichuan University
Co-authored papers
1
Orit Jacboson
Co-authored papers
1
James R Mansfield
Institute for Biodiagnostics, National Research Council Canada
Co-authored papers
1
Peter S Conti
Keck School of Medicine of USC
Co-authored papers
1
1 - 23